541 related articles for article (PubMed ID: 27025436)
1. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
[TBL] [Abstract][Full Text] [Related]
2. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
4. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
5. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
[TBL] [Abstract][Full Text] [Related]
6. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
[TBL] [Abstract][Full Text] [Related]
8. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II).
Berry N; Mauri L; Feldman T; Komtebedde J; van Veldhuisen DJ; Solomon SD; Massaro JM; Shah SJ
Am Heart J; 2020 Aug; 226():222-231. PubMed ID: 32629295
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
[TBL] [Abstract][Full Text] [Related]
11. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
[TBL] [Abstract][Full Text] [Related]
12. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
[TBL] [Abstract][Full Text] [Related]
13. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.
Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ
JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494
[TBL] [Abstract][Full Text] [Related]
14. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
[TBL] [Abstract][Full Text] [Related]
15. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
[TBL] [Abstract][Full Text] [Related]
16. Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
Obokata M; Reddy YNV; Shah SJ; Kaye DM; Gustafsson F; Hasenfuβ G; Hoendermis E; Litwin SE; Komtebedde J; Lam C; Burkhoff D; Borlaug BA
J Am Coll Cardiol; 2019 Nov; 74(21):2539-2550. PubMed ID: 31753198
[TBL] [Abstract][Full Text] [Related]
17. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
[TBL] [Abstract][Full Text] [Related]
18. Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.
Litwin SE; Komtebedde J; Hu M; Burkhoff D; Hasenfuß G; Borlaug BA; Solomon SD; Zile MR; Mohan RC; Khawash R; Sverdlov AL; Fail P; Chung ES; Kaye DM; Blair J; Eicher JC; Hummel SL; Zirlik A; Westenfeld R; Hayward C; Gorter TM; Demers C; Shetty R; Lewis G; Starling RC; Patel S; Gupta DK; Morsli H; Penicka M; Cikes M; Gustafsson F; Silvestry FE; Rowin EJ; Cutlip DE; Leon MB; Kitzman DW; Kleber FX; Shah SJ;
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1103-1117. PubMed ID: 36939661
[TBL] [Abstract][Full Text] [Related]
19. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
Del Trigo M; Bergeron S; Bernier M; Amat-Santos IJ; Puri R; Campelo-Parada F; Altisent OA; Regueiro A; Eigler N; Rozenfeld E; Pibarot P; Abraham WT; Rodés-Cabau J
Lancet; 2016 Mar; 387(10025):1290-7. PubMed ID: 27025435
[TBL] [Abstract][Full Text] [Related]
20. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Koepp KE; Melenovsky V
J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
